AFYREN Secures Responsible Care® Certification and Releases Sustainability Report

AFYREN, a greentech company listed on Euronext, has obtained the “Responsible Care® - Confirmed Diagnosis” certification for its AFYREN NEOXY site. This milestone, presented by France Chimie, underscores AFYREN's commitment to Corporate Social Responsibility (CSR). In tandem, the firm published its second sustainability report that aligns with the Corporate Sustainability Reporting Directive (CSRD). The certification and report reflect AFYREN's dedication to ethical and sustainable practices within the chemical industry.

The comprehensive assessment leading to the certification was a collaborative effort by AFYREN’s Quality, Health, Safety, and Environment (QHSE) and CSR teams. It involved multi-departmental interviews, resulting in a clear and tangible CSR roadmap. The initiative emphasized product quality monitoring, echoing AFYREN's dedication to customer service.

The newly released sustainability report highlights AFYREN's progress with updated performance indicators while maintaining transparency and accountability. This proactive communication aims to strengthen stakeholder engagement and reflects the company's high standards in CSR, environmental impact minimization, and social commitments.